Error message

Deprecated function: The each() function is deprecated. This message will be suppressed on further calls in menu_set_active_trail() (line 2405 of /home/customer/www/secids.com/public_html/includes/menu.inc).

9 February 2021 Meeting_Covid- 19 Vaccination in SEE countries- Challenges and Opportunities

 

 

 

 

 

 

 

9 February 2021: Covid- 19  Vaccination in SEE countries- Challenges and Opportunities  was the theme which brought together health experts from SEEHN Member States, WHO Regional Office for Europe, Slovenia, CDC, ECDC and Kosovo*,  in a virtual meeting organized by SEE Health Network – (SEEHN) and its Regional Health Development Center on Surveillance and Control of Infectious Diseases -(SECID)

SEE Countries of South East Europe (Albania, Bosnia and Herzegovina, Bulgaria, Croatia, North Macedonia, Montenegro, Republic of Moldova, Romania, Serbia and Kosovo*) are collaborating for many years to strengthen and improve the surveillance and control of infectious diseases.

During the last year through a partnership of SECID and SEEHN Secretariat with Task Force for Global Health and CDC Atlanta, WHO Euro and ECDC have been collaborating to establish and improve influenza vaccination, improve NITAG-s or vaccine expert group capacities and vaccine management.

The aim of this important and fruitful meeting was to identify the challenges and opportunities that the SEE countries are facing during and for the upcoming COVID-19 Vaccination and map the current and future needs.

More than 40 participants; NITAG representatives and managers of National Immunization Program from respective countries, joined the conversation and shared valuable experience on the state of affairs in their countries.

The objectives of the meeting were to:

1. Explore country’s challenges to ensure COVID-19 vaccines and get prepared.

2. Identify the challenges the country’s NITAG-s or expert groups are facing to prepare

COVID -19 vaccination’s recommendations.

3. Identify challenges and opportunities to implement COVID-19 vaccination.

4. Explore the level of vaccine acceptance and refusal in SEE Countries.

5. Identify the challenges of COVID-19 vaccination monitoring.